Original Research

DOI: 10.4244/EIJ-D-26-00416

Long-term clinical outcomes of high-risk plaques with negative fractional flow reserve: the PECTUS-obs study

Rick H.J.A. Volleberg1, MD; Jan-Quinten Mol1, MD; Geert A.A. Versteeg1, MD; Joske van der Zande1,2, MSc; Anouar Belkacemi3, MD, PhD; Renicus S. Hermanides4, MD, PhD; Martijn Meuwissen5, MD, PhD; Alexey V. Protopopov6,7, MD, PhD; Peep Laanmets8, MD; Oleg V. Krestyaninov9, MD, PhD; Casper F. Laclé10, MD; Rohit M. Oemrawsingh5,11, MD, PhD; Jan-Peter van Kuijk12, MD, PhD; Karin Arkenbout13,14, MD, PhD; Dirk J. van der Heijden4,15, MD, PhD; Saman Rasoul16,17, MD, PhD; Erik Lipsic18,19, MD, Laura Rodwell, PhD; Cyril Camaro1, MD; Peter Damman1, MD, PhD; Tomasz Roleder20, MD, PhD; Elvin Kedhi21, MD, PhD; Maarten A.H. van Leeuwen4, MD, PhD; Robert-Jan M. van Geuns1, MD, PhD; Niels van Royen1, MD, PhD

Abstract

Background: High-risk plaques (HRP) in non-flow limiting, deferred non-culprit lesions have been associated with adverse short-term cardiovascular outcome after myocardial infarction (MI). However, the long-term prognostic implications remain largely unknown.

Aims: This study sought to evaluate the long-term association between HRP and clinical outcome after MI.

Methods: In the prospective, observational PECTUS-obs study, 438 patients with recent MI underwent optical coherence tomography (OCT) of all fractional flow reserve-negative non-culprit lesions. Patients were grouped according to the presence or absence of at least one OCT-identified HRP. The current study evaluates the final long-term outcome. The primary patient-level endpoint was defined as major adverse cardiovascular events (MACE), a composite of cardiac death, nonfatal MI or unplanned revascularization, excluding all periprocedural, indeterminate and all stent failure-related events.

Results: After a median follow-up of 1828 days (IQR1821-1842), presence of at least one HRP was associated with MACE (HR 1.87, 95% CI 1.11-3.14, p=0.017). Among the individual endpoint components, non-fatal MI (HR 4.07, 95% CI 1.23-13.52, p=0.013) and unplanned revascularization (HR 1.97, 95% CI 1.07-3.64, p=0.027) occurred more frequently in patients with at least one HRP. In an exploratory landmark analysis, the risk associated with presence of HRP was observed only during the first two years of follow-up. The lesion-level incidence of target lesion failure did not differ significantly between groups (HR 1.65, 95% CI 0.91-2.96, p=0.097).

Conclusions: Non-flow limiting but high-risk non-culprit plaques are associated with adverse patient-level clinical outcome during long-term follow-up after MI, potentially with a more pronounced short-term risk. Clinical Trial Registration NCT03857971

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Receive our newsletter


Key metrics

Suggested by Cory

Original Research

10.4244/EIJ-D-25-01268 Jun 1, 2026
Early outcomes of redo-TAVI with the SAPIEN 3 platform: the prospective, multicentre ReTAVI registry
Tarantini G et al

Expert consensus

10.4244/EIJ-D-24-01126 May 20, 2025
SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women
Baron S et al
open access
Trending articles
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
87.2

State-of-the-Art

10.4244/EIJ-D-25-00266 Jan 19, 2026
Lesion stratification with intracoronary imaging
McGarvey M et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
34.8

Original Research

10.4244/EIJ-D-25-01006 Mar 16, 2026
Clinical outcomes and haemodynamic response after blinded stress assessment of moderate aortic stenosis
Eerdekens R et al
24.15

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
24.15

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
23.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
22.2

Viewpoint

10.4244/EIJ-D-25-01066 May 4, 2026
Intracoronary imaging guidance for de novo coronary lesion treatment with drug-coated balloons
Amabile N et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved